** BofA Global Research downgrades health insurer Centene CNC.N to "underperform" from "neutral", trims PT to $30 from $52
** Medicaid and Affordable Care Act $(ACA)$ exchange markets are slowing due to the new Reconciliation Bill, and there's a strong chance that enhanced government subsidies for ACA coverage will expire after 2025, BofA analysts say
** Brokerage expects at least $2.75 per share of pressure from the ACA exchanges, plus higher costs in Medicaid
** Membership declines driven by the new legislation are expected to slow CNC’s revenue growth through 2029, while shifting insurance risks and potential Medicaid rate cuts will make it more difficult for the company to restore normal profit margins, BofA analysts say
** As of last close, CNC stock down 50.5% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。